CATEGORY

Business

Enphase Predicts Weak Revenue as Solar Demand Slumps. What Analysts Say.

Enphase Forecasts Weak Revenue as Demand Slumps. What Wall Street Is Saying. Source link

Block upgraded, Southwest downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that...

Solar Energy Hot And Cold; FSLR Stock Bolts On Earnings, NXT Breaks Out; Enphase Unravels

First Solar (FSLR) stock rocketed, then retreated early Friday as analysts ratcheted price targets higher for the solar energy systems provider following its...

Techs Lead Rebound As Inflation Cools

The Dow Jones rose Friday, along with the S&P 500 and especially the Nasdaq, as the stock market rally looks to rebound after...

Goldman Sachs Predicts up to 120% Rally for These 2 Stocks — Here’s Why They Have Solid Upside

It’s no secret that the big gains in the stock market this year have been on account of only a select number of...

Hands On With Google Search’s Answer to ChatGPT

Last weekend, I turned to Google Search for help figuring out how many stamps I needed to put on an 8-ounce piece of...

Disney’s Magic Will Return. It’s Time to Buy the Stock.

Walt Disney’s films and theme parks have captured the hearts of millions, but its stock performance has been less than enchanting. Once a...

Biogen to Buy Reata Pharmaceuticals in $7.3 Billion Deal

Biogen to Buy Reata Pharmaceuticals in $7.3 Billion Deal Source link

Mark Zuckerberg Snatches Prized Bragging Right From Warren Buffett

Mark Zuckerberg may taunt Elon Musk with a cage match. But he just toppled Warren Buffett for financial bragging rights much more valuable...

Latest news